Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,3612,380 of 20,252 grants

Completed SBIR-STTR RPGS
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
NATIONAL CANCER INSTITUTE Nob Hill Therapeutics, Inc United States 2023 – 2025

Project Summary Lung cancer (LC) with over 2 million cases/year worldwide also remains the leading cause of cancer- related death in the US and Europe. Treating LC remains challeng...

$8.61M
USD
Completed SBIR-STTR RPGS
Validation of the Genetically Malleable Oncopig Hepatocellular carcinoma (HCC) Model for Targeted Therapeutic Development
NATIONAL CANCER INSTITUTE Sus Clinicals, Inc United States 2023 – 2025

PROJECT ABSTRACT: The goal of this Phase II SBIR proposal is to further validate the genetically defined Oncopig hepatocellular carcinoma (HCC) model—capable of modeling diverse HC...

$9.64M
USD
Completed SBIR-STTR RPGS
ADEPT-STAR therapy for high risk neuroblastoma
NATIONAL CANCER INSTITUTE Expression Therapeutics United States 2023 – 2024

PROJECT SUMMARY Cancer remains a primary health concern despite significant advancements in treatment. In the past decade, cell and gene (C&G) therapies along with immuno-oncol...

$4M
USD
Completed SBIR-STTR RPGS
7HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors
NATIONAL CANCER INSTITUTE 7 Hills Pharma, Llc United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Immuno-oncology (IO) therapies, particularly immune checkpoint inhibitors (ICIs) such as nivolumab (anti-PD- 1) and ipilimumab (anti-CTLA-4) have made rapi...

$9.99M
USD
Active RESEARCH CENTERS
1/2 Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership
NATIONAL CANCER INSTITUTE San Diego State University United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT – OVERALL The Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership’s overarching goals are to further increase SDSU’s cancer researc...

$12.06M
USD
Active RESEARCH CENTERS
Single-Cell, Spatial and Functional Dissection of Cancer Cell States, Co-Evolving Ecosystems, and Vulnerabilities During Tumor Progression and Metastasis
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

Aggressive cancers often lack pharmacologically actionable mutations and do not respond to immune checkpoint blockade, thus deriving only modest clinical benefit from targeted and...

Active RESEARCH CENTERS
Drug Mechanism of Action-based targeting of tumor subpopulations
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

Patients with aggressive cancers often present with no pharmacologically actionable mutations and fail to respond to immune checkpoint blockade, thus deriving only modest improveme...

Active RESEARCH CENTERS
Outreach Core
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

Project Summary Crucial to the long-lasting impact of the Center for Cancer Systems Therapeutics (CaST) is a robust and inclusive Outreach effort. The community and computational i...

Active RESEARCH CENTERS
Advanced Single Cell Technology Innovation Core
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

PROJECT SUMMARY The proposed Cancer Systems Therapeutics (CaST) Center focuses on understanding and targeting molecularly distinct yet co-existing cell states and transitions that...

Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT/SUMMARY: Administrative Core The Administrative Core of our proposed Stanford Center for Cancer Systems Biology (CCSB) will provide the logistical support for all coordina...

Active NON-SBIR/STTR RPGS
Expanding early cancer detection with high throughput OCEANA - Ovarian Cancer Exosome Analysis with Nanoplasmonic Array
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2023 – 2028

Ovarian cancer (OvCa) remains the most lethal gynecologic cancer in the United States. Early detection through screening, particularly of high-risk populations, is an appealing str...

$8.78M
USD
Active NON-SBIR/STTR RPGS
The role of the cohesin complex in hematopoietic transformation and leukemia maintenance
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

PROJECT SUMMARY In this proposal, we will define the effects of epigenetic dysregulation via Stag2 loss on three-dimensional chromatin structure and transcriptional regulation. We...

$1.06M
USD
Active RESEARCH CENTERS
Integrating cervical cancer screening within the outpatient emergency departments in Kenya
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

Integrating cervical cancer screening within the outpatient emergency departments in Kenya This application is in response to Notice of Special Interest (NOSI): Administrative Supp...

$1.25M
USD
Active RESEARCH CENTERS
Policy implementation for cancer control in Nigeria
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Project Summary This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA- 24-039. Policy is a powerful tool for achieving cance...

$1.5M
USD
Active RESEARCH CENTERS
Advanced Single Cell Technology Innovation Core
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

PROJECT SUMMARY The proposed Cancer Systems Therapeutics (CaST) Center focuses on understanding and targeting molecularly distinct yet co-existing cell states and transitions that...

Active RESEARCH CENTERS
Enhanced Cervical Cancer Screening Adoption and Treatment Linkage for HIV positive Women in Kenya (eCASCADE-Kenya)
NATIONAL CANCER INSTITUTE Emory University United States 2023 – 2028

CENTER OVERALL: PROGRAM SUMMARY / ABSTRACT While considerable evidence is available for screening and early treatment of breast and cervical cancers, huge gaps remain in equitable...

Active RESEARCH CENTERS
Research and Capacity Building Core
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Nigeria, Africa’s most populous country, bears the second highest burden of cancer cases (11%) and deaths (12%) in Africa.1 Evidence-based cancer control interventions such as vacc...

Active RESEARCH CENTERS
Drug Mechanism of Action-based targeting of tumor subpopulations
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

The primary site of prostate cancer metastasis is bone, which is associated with significant morbidity and mortality; yet there are few curative treatment options, in part due to t...

Active RESEARCH CENTERS
Shared Resource Core 1: Molecular Data Science and Advanced Dosimetry
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY The convergence of radiation oncology, cancer genomics, data science, computational modeling, and artificial intelligence presents spectacular opportunities and cha...

Active NON-SBIR/STTR RPGS
Preventing invasive prostate cancer
NATIONAL CANCER INSTITUTE University of Nebraska Medical Center United States 2023 – 2028

Abstract: Cell motility is required for in situ cancer to form invasive primary prostate cancer (PCa). Inhibiting motility would intercept formation of invasive cancer. Until now i...

$5.36M
USD